👉 Every biotech founder knows the burn rate clock is ticking. You’ve mapped your milestones. You’ve got 12, maybe 18 months of runway. You’re pushing the science forward. But at some point, usually right after a delayed assay or a no from a lead investor, something shifts. 👉 Suddenly, the calendar starts driving your decisions more than the science does. You catch yourself wondering if the data is “good enough” to show. You rush internal meetings to hit external expectation

While you’re waiting for quarterly reports to tell you what’s happening in your market, your competitors already know. They’re tracking...

Artificial intelligence has officially crossed from buzzword to boardroom. Every pitch deck seems to mention it. Every investor panel...

If your company still operates the same way it did three years ago, you’re already behind. The pace of change in biotech has never been...

If you’ve been searching for months to hire a scientist, regulatory lead, or business development partner — but keep getting average or...